We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
+10.82%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$48.6B
AUM Growth
+$3.08B
(+6.8%)
Cap. Flow
+$3.24M
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
3,030
New
136
Increased
1,065
Reduced
1,247
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$806M |
| 2 |
Prologis
PLD
|
+$81.5M |
| 3 |
SABRP
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
|
+$72.2M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$71M |
| 5 |
SLB Ltd
SLB
|
+$65.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$109M |
| 2 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$80.1M |
| 3 |
Applied Materials
AMAT
|
+$46.5M |
| 4 |
Booking.com
BKNG
|
+$43.8M |
| 5 |
Amazon
AMZN
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 13.97% |
| 4 | Real Estate | 9.14% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Vera Bradley
VRA
$95.3M
| $39.7K | ﹤0.01% |
8,775
-90,820
| -91% | -$332K |
|
2652
Silicom
SILC
$271M
| $38.2K | ﹤0.01% |
897
-2,973
| -77% | -$122K |
|
2653
Ocular Therapeutix
OCUL
$2.19B
| $38.1K | ﹤0.01% |
13,561
-17,382
| -56% | -$57.5K |
|
2654
Lumentum
LITE
$68.4B
| $35.9K | ﹤0.01% |
688
-3,407
| -83% | -$209K |
|
2655
TAL Education Group
TAL
$6.63B
| $35.1K | ﹤0.01% |
4,981
-67,743
| -93% | -$375K |
|
2656
4D Molecular Therapeutics
FDMT
$607M
| $34.8K | ﹤0.01% |
1,569
| – | – |
|
|
JBIO
2657
Jade Biosciences
JBIO
$1.44B
| $34.4K | ﹤0.01% |
34
| – | – |
|
2658
Comtech Telecommunications
CMTL
$54.5M
| $33.8K | ﹤0.01% |
2,784
-6,481
| -70% | -$73.1K |
|
|
TRHC
2659
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $33.6K | ﹤0.01% |
6,779
| – | – |
|
2660
Inovio Pharmaceuticals
INO
$78.1M
| $32.4K | ﹤0.01% |
1,733
| – | – |
|
|
EBIX
2661
DELISTED
Ebix Inc
EBIX
| $31.9K | ﹤0.01% |
1,600
| – | – |
|
2662
Tandem Diabetes Care
TNDM
$1.6B
| $31.7K | ﹤0.01% |
706
| – | – |
|
2663
AnaptysBio
ANAB
$1.71B
| $31.5K | ﹤0.01% |
1,018
| – | – |
|
2664
Forestar Group
FOR
$1.47B
| $31.5K | ﹤0.01% |
2,046
-3,452
| -63% | -$45.7K |
|
2665
Geron
GERN
$1.03B
| $31.5K | ﹤0.01% |
13,015
| – | – |
|
|
MIXT
2666
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $31.3K | ﹤0.01% |
4,453
-2,953
| -40% | -$22.9K |
|
2667
Trustmark
TRMK
$2.78B
| $30.9K | ﹤0.01% |
884
| – | – |
|
|
MAGN
2668
Magnera Corp
MAGN
$445M
| $30.8K | ﹤0.01% |
853
-232
| -21% | -$9.47K |
|
2669
iQIYI
IQ
$1.34B
| $30.8K | ﹤0.01% |
5,809
| – | – |
|
2670
Preformed Line Products
PLPC
$2.47B
| $29.7K | ﹤0.01% |
357
-1,075
| -75% | -$88.7K |
|
2671
Bausch Health
BHC
$2.29B
| $29.7K | ﹤0.01% |
4,700
-10,466
| -69% | -$73.1K |
|
2672
Olema Pharmaceuticals
OLMA
$916M
| $29.4K | ﹤0.01% |
11,991
-9,597
| -44% | -$28K |
|
2673
Invesco Mortgage Capital
IVR
$804M
| $29.3K | ﹤0.01% |
2,304
| – | – |
|
2674
Nano X Imaging
NNOX
$76.6M
| $29.3K | ﹤0.01% |
+3,972
| New | +$44K |
|
2675
Quantum Corp
QMCO
$841M
| $27.8K | ﹤0.01% |
1,274
-6,320
| -83% | -$155K |
|
Similar funds
VAM
Russell Investments Group's Q4 2022 Portfolio in Review
As of Q4 2022, Russell Investments Group held 3,030 positions worth $48.6B, up 6.8% from $45.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Russell Investments Group's Q4 2022 filing shows 136 new, 1,065 increased, 1,247 reduced and 140 closed positions. Its largest new stake was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K. The largest sale was Duke Realty Corp., an estimated $109M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Russell Investments Group's largest Q4 2022 buy was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K.
- Russell Investments Group added most to Bank of America Series L in Q4 2022, an estimated $806M increase.
- Russell Investments Group's biggest Q4 2022 reduction was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $80.1M.
- Russell Investments Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $109M.
- Russell Investments Group's ten largest holdings make up 14% of its $48.6B portfolio in Q4 2022.
- Russell Investments Group opened 136 new positions and closed 140 in Q4 2022.
- Russell Investments Group's portfolio value rose 6.8% quarter-over-quarter to $48.6B.
Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.